サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751692

希少胃腸疾患治療の世界市場に関する洞察、2031年までの予測

Global Rare Gastrointestinal Diseases Treatment Market Insights, Forecast to 2031

出版日
発行
QYResearch
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
希少胃腸疾患治療の世界市場に関する洞察、2031年までの予測
出版日: 2025年06月19日
発行: QYResearch
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、希少胃腸疾患治療 (Rare Gastrointestinal Diseases Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の希少胃腸疾患治療の市場規模成長率：タイプ別: 2020 VS 2024 VS 2031
    • Drugs
    • Device
  • 市場：用途別
    • 世界の希少胃腸疾患治療の市場シェア：用途別: 2020 VS 2024 VS 2031
    • Eosinophilic Gastroenteritis
    • Hercksprung's Disease
    • Chronic Intestinal Pseudo-obstruction
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の希少胃腸疾患治療の市場展望 (2020-2031)
  • 世界の希少胃腸疾患治療の市場成長トレンド：地域別
    • 世界の希少胃腸疾患治療 市場規模：地域別: 2020 VS 2024 VS 2031
    • 希少胃腸疾患治療 市場規模：地域別 (2020-2031)
  • 希少胃腸疾患治療 市場動向
    • 希少胃腸疾患治療 業界動向
    • 希少胃腸疾患治療 市場の促進要因
    • 希少胃腸疾患治療 市場の課題
    • 希少胃腸疾患治療 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の収益 希少胃腸疾患治療 ：競合別
    • 世界の希少胃腸疾患治療の収益：企業別 (2020-2025)
    • 世界の希少胃腸疾患治療の収益シェア：企業別 (2020-2025)
  • 世界の希少胃腸疾患治療の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 希少胃腸疾患治療, 売上高ランキング, 2023 VS 2024 VS 2025
  • 世界の市場集中度
    • 世界の希少胃腸疾患治療 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 希少胃腸疾患治療 収益 2024年
  • 世界の主要企業 希少胃腸疾患治療 本社 および提供地域
  • 世界の主要企業 希少胃腸疾患治療, 製品およびアプリケーション
  • 世界の主要企業 希少胃腸疾患治療, 業界参入時期
  • M&A, 拡張計画

第4章 内訳データ：タイプ別

  • 世界の希少胃腸疾患治療の市場規模実績：タイプ別 (2020-2025)
  • 世界の希少胃腸疾患治療の市場規模予測：タイプ別 (2026-2031)

第5章 内訳データ：用途別

  • 世界の希少胃腸疾患治療の市場規模実績：用途別 (2020-2025)
  • 世界の希少胃腸疾患治療の市場規模予測：用途別 (2026-2031)

第6章 北米

  • 北米の希少胃腸疾患治療 市場規模 (2020-2031)
  • 北米の市場規模：タイプ別
    • 北米の希少胃腸疾患治療 市場規模：タイプ別 (2020-2031)
    • 北米の希少胃腸疾患治療の市場シェア：タイプ別 (2020-2031)
  • 北米の市場規模：用途別
    • 北米の希少胃腸疾患治療 市場規模：用途別 (2020-2031)
    • 北米の希少胃腸疾患治療の市場シェア：用途別 (2020-2031)
  • 北米の市場規模：国別
    • 北米の希少胃腸疾患治療 市場規模：国別: 2020 VS 2024 VS 2031
    • 北米の希少胃腸疾患治療 市場規模：国別 (2020-2031)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の希少胃腸疾患治療 市場規模 (2020-2031)
  • 欧州の市場規模：タイプ別
    • 欧州の希少胃腸疾患治療 市場規模：タイプ別 (2020-2031)
    • 欧州の希少胃腸疾患治療の市場シェア：タイプ別 (2020-2031)
  • 欧州の市場規模：用途別
    • 欧州の希少胃腸疾患治療 市場規模：用途別 (2020-2031)
    • 欧州の希少胃腸疾患治療の市場シェア：用途別 (2020-2031)
  • 欧州の市場規模：国別
    • 欧州の希少胃腸疾患治療 市場規模：国別: 2020 VS 2024 VS 2031
    • 欧州の希少胃腸疾患治療 市場規模：国別 (2020-2025)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の希少胃腸疾患治療 市場規模 (2020-2031)
  • 中国の市場規模：タイプ別
    • 中国の希少胃腸疾患治療 市場規模：タイプ別 (2020-2031)
    • 中国の希少胃腸疾患治療の市場シェア：タイプ別 (2020-2031)
  • 中国の市場規模：用途別
    • 中国の希少胃腸疾患治療 市場規模：用途別 (2020-2031)
    • 中国の希少胃腸疾患治療の市場シェア：用途別 (2020-2031)

第9章 アジア（中国を除く）

  • アジア地域 希少胃腸疾患治療 市場規模 (2020-2031)
  • アジア地域 市場規模：タイプ別
    • アジア地域 希少胃腸疾患治療 市場規模：タイプ別 (2020-2031)
    • アジア地域 希少胃腸疾患治療の市場シェア：タイプ別 (2020-2031)
  • アジア地域 市場規模：用途別
    • アジア地域 希少胃腸疾患治療 市場規模：用途別 (2020-2031)
    • アジア地域 希少胃腸疾患治療の市場シェア：用途別 (2020-2031)
  • アジア地域 市場規模：地域別
    • アジア地域 希少胃腸疾患治療 市場規模：地域別: 2020 VS 2024 VS 2031
    • アジア地域 希少胃腸疾患治療 市場規模：地域別 (2020-2031)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 希少胃腸疾患治療 市場規模 (2020-2031)
  • 中近東・アフリカ・中南米 市場規模：タイプ別
    • 中近東・アフリカ・中南米 希少胃腸疾患治療 市場規模：タイプ別 (2020-2031)
    • 中近東・アフリカ・中南米 希少胃腸疾患治療の市場シェア：タイプ別 (2020-2031)
  • 中近東・アフリカ・中南米 市場規模：用途別
    • 中近東・アフリカ・中南米 希少胃腸疾患治療 市場規模：用途別 (2020-2031)
    • 中近東・アフリカ・中南米の市場シェア：用途別 (2020-2031)
  • 中近東・アフリカ・中南米 市場規模：国別
    • 中近東・アフリカ・中南米 希少胃腸疾患治療 市場規模：国別: 2020 VS 2024 VS 2031
    • 中近東・アフリカ・中南米 希少胃腸疾患治療 市場規模：国別 (2020-2031)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Takeda Pharmaceutical
  • Nestle Health Science
  • Mirum Pharmaceutical
  • Recordati Rare Diseases
  • Zealand Pharma
  • Ironwood Pharmaceutical
  • Ipsen
  • Univar Solutions
  • Tilray Brand
  • 4D Molecular Therapeutics
  • Chiasma
  • Orphalan
  • Santhera Pharmaceutical

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

Table 1. Global Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Drugs

Table 3. Key Players of Device

Table 4. Global Rare Gastrointestinal Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Rare Gastrointestinal Diseases Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Market Size by Region (2020-2031) & (US$ Million)

Table 7. Global Rare Gastrointestinal Diseases Treatment Market Share by Region (2020-2031)

Table 8. Market Trends

Table 9. Market Drivers

Table 10. Market Challenges

Table 11. Market Restraints

Table 12. Global Rare Gastrointestinal Diseases Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 13. Global Rare Gastrointestinal Diseases Treatment Market Share by Players (2020-2025)

Table 14. Global Top Rare Gastrointestinal Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Gastrointestinal Diseases Treatment as of 2024)

Table 15. Global Rare Gastrointestinal Diseases Treatment Industry Ranking 2023 VS 2024

Table 16. Global 5 Largest Players Market Share by Rare Gastrointestinal Diseases Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 17. Global Key Players of Rare Gastrointestinal Diseases Treatment, Headquarters and Area Served

Table 18. Global Key Players of Rare Gastrointestinal Diseases Treatment, Product and Application

Table 19. Global Key Players of Rare Gastrointestinal Diseases Treatment, Date of Enter into This Industry

Table 20. Mergers & Acquisitions, Expansion Plans

Table 21. Global Market Size by Type (2020-2025) & (US$ Million)

Table 22. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Type (2020-2025)

Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 24. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Type (2026-2031)

Table 25. Global Market Size by Application (2020-2025) & (US$ Million)

Table 26. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Application (2020-2025)

Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 28. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Application (2026-2031)

Table 29. North America Market Size by Type (2020-2031) & (US$ Million)

Table 30. North America Market Size by Application (2020-2031) & (US$ Million)

Table 31. North America Rare Gastrointestinal Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Market Size by Country (2020-2031) & (US$ Million)

Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 35. Europe Rare Gastrointestinal Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 37. China Market Size by Type (2020-2031) & (US$ Million)

Table 38. China Market Size by Application (2020-2031) & (US$ Million)

Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 41. Asia Rare Gastrointestinal Diseases Treatment Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 47. Takeda Pharmaceutical Company Details

Table 48. Takeda Pharmaceutical Business Overview

Table 49. Takeda Pharmaceutical Rare Gastrointestinal Diseases Treatment Product

Table 50. Takeda Pharmaceutical Revenue (2020-2025) & (US$ Million)

Table 51. Takeda Pharmaceutical Recent Development

Table 52. Nestle Health Science Company Details

Table 53. Nestle Health Science Business Overview

Table 54. Nestle Health Science Rare Gastrointestinal Diseases Treatment Product

Table 55. Nestle Health Science Revenue (2020-2025) & (US$ Million)

Table 56. Nestle Health Science Recent Development

Table 57. Mirum Pharmaceutical Company Details

Table 58. Mirum Pharmaceutical Business Overview

Table 59. Mirum Pharmaceutical Rare Gastrointestinal Diseases Treatment Product

Table 60. Mirum Pharmaceutical Revenue (2020-2025) & (US$ Million)

Table 61. Mirum Pharmaceutical Recent Development

Table 62. Recordati Rare Diseases Company Details

Table 63. Recordati Rare Diseases Business Overview

Table 64. Recordati Rare Diseases Rare Gastrointestinal Diseases Treatment Product

Table 65. Recordati Rare Diseases Revenue (2020-2025) & (US$ Million)

Table 66. Recordati Rare Diseases Recent Development

Table 67. Zealand Pharma Company Details

Table 68. Zealand Pharma Business Overview

Table 69. Zealand Pharma Rare Gastrointestinal Diseases Treatment Product

Table 70. Zealand Pharma Revenue (2020-2025) & (US$ Million)

Table 71. Zealand Pharma Recent Development

Table 72. Ironwood Pharmaceutical Company Details

Table 73. Ironwood Pharmaceutical Business Overview

Table 74. Ironwood Pharmaceutical Rare Gastrointestinal Diseases Treatment Product

Table 75. Ironwood Pharmaceutical Revenue (2020-2025) & (US$ Million)

Table 76. Ironwood Pharmaceutical Recent Development

Table 77. Ipsen Company Details

Table 78. Ipsen Business Overview

Table 79. Ipsen Rare Gastrointestinal Diseases Treatment Product

Table 80. Ipsen Revenue (2020-2025) & (US$ Million)

Table 81. Ipsen Recent Development

Table 82. Univar Solutions Company Details

Table 83. Univar Solutions Business Overview

Table 84. Univar Solutions Rare Gastrointestinal Diseases Treatment Product

Table 85. Univar Solutions Revenue (2020-2025) & (US$ Million)

Table 86. Univar Solutions Recent Development

Table 87. Tilray Brand Company Details

Table 88. Tilray Brand Business Overview

Table 89. Tilray Brand Rare Gastrointestinal Diseases Treatment Product

Table 90. Tilray Brand Revenue (2020-2025) & (US$ Million)

Table 91. Tilray Brand Recent Development

Table 92. 4D Molecular Therapeutics Company Details

Table 93. 4D Molecular Therapeutics Business Overview

Table 94. 4D Molecular Therapeutics Rare Gastrointestinal Diseases Treatment Product

Table 95. 4D Molecular Therapeutics Revenue (2020-2025) & (US$ Million)

Table 96. 4D Molecular Therapeutics Recent Development

Table 97. Chiasma Company Details

Table 98. Chiasma Business Overview

Table 99. Chiasma Rare Gastrointestinal Diseases Treatment Product

Table 100. Chiasma Revenue (2020-2025) & (US$ Million)

Table 101. Chiasma Recent Development

Table 102. Orphalan Company Details

Table 103. Orphalan Business Overview

Table 104. Orphalan Rare Gastrointestinal Diseases Treatment Product

Table 105. Orphalan Revenue (2020-2025) & (US$ Million)

Table 106. Orphalan Recent Development

Table 107. Santhera Pharmaceutical Company Details

Table 108. Santhera Pharmaceutical Business Overview

Table 109. Santhera Pharmaceutical Rare Gastrointestinal Diseases Treatment Product

Table 110. Santhera Pharmaceutical Revenue (2020-2025) & (US$ Million)

Table 111. Santhera Pharmaceutical Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Rare Gastrointestinal Diseases Treatment Market Share by Type: 2024 VS 2031

Figure 3. Drugs Features

Figure 4. Device Features

Figure 5. Global Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Global Rare Gastrointestinal Diseases Treatment Market Share by Application: 2024 VS 2031

Figure 7. Eosinophilic Gastroenteritis Case Studies

Figure 8. Hercksprung's Disease Case Studies

Figure 9. Chronic Intestinal Pseudo-obstruction Case Studies

Figure 10. Rare Gastrointestinal Diseases Treatment Report Years Considered

Figure 11. Global Rare Gastrointestinal Diseases Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Rare Gastrointestinal Diseases Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Rare Gastrointestinal Diseases Treatment Market Share by Region: 2024 VS 2031

Figure 14. Global Rare Gastrointestinal Diseases Treatment Market Share by Players in 2024

Figure 15. Global Top Rare Gastrointestinal Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Gastrointestinal Diseases Treatment as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Rare Gastrointestinal Diseases Treatment Revenue in 2024

Figure 17. North America Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)

Figure 19. North America Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)

Figure 20. North America Rare Gastrointestinal Diseases Treatment Market Share by Country (2020-2031)

Figure 21. United States Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)

Figure 25. Europe Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)

Figure 26. Europe Rare Gastrointestinal Diseases Treatment Market Share by Country (2020-2031)

Figure 27. Germany Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. China Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. China Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)

Figure 35. China Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)

Figure 36. Asia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)

Figure 38. Asia Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)

Figure 39. Asia Rare Gastrointestinal Diseases Treatment Market Share by Region (2020-2031)

Figure 40. Japan Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. South Korea Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. China Taiwan Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)

Figure 48. Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)

Figure 49. Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Share by Country (2020-2031)

Figure 50. Brazil Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Mexico Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Turkey Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Israel Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. GCC Countries Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Takeda Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 57. Nestle Health Science Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 58. Mirum Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 59. Recordati Rare Diseases Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 60. Zealand Pharma Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 61. Ironwood Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 62. Ipsen Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 63. Univar Solutions Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 64. Tilray Brand Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 65. 4D Molecular Therapeutics Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 66. Chiasma Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 67. Orphalan Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 68. Santhera Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

目次

This research report focuses on the Rare Gastrointestinal Diseases Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Drugs
    • 1.2.3 Device
  • 1.3 Market by Application
    • 1.3.1 Global Rare Gastrointestinal Diseases Treatment Market Share by Application: 2020 VS 2024 VS 2031
    • 1.3.2 Eosinophilic Gastroenteritis
    • 1.3.3 Hercksprung's Disease
    • 1.3.4 Chronic Intestinal Pseudo-obstruction
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Rare Gastrointestinal Diseases Treatment Market Perspective (2020-2031)
  • 2.2 Global Rare Gastrointestinal Diseases Treatment Growth Trends by Region
    • 2.2.1 Global Rare Gastrointestinal Diseases Treatment Market Size by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Rare Gastrointestinal Diseases Treatment Market Size by Region (2020-2031)
  • 2.3 Rare Gastrointestinal Diseases Treatment Market Dynamics
    • 2.3.1 Rare Gastrointestinal Diseases Treatment Industry Trends
    • 2.3.2 Rare Gastrointestinal Diseases Treatment Market Drivers
    • 2.3.3 Rare Gastrointestinal Diseases Treatment Market Challenges
    • 2.3.4 Rare Gastrointestinal Diseases Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Rare Gastrointestinal Diseases Treatment by Players
    • 3.1.1 Global Rare Gastrointestinal Diseases Treatment Revenue by Players (2020-2025)
    • 3.1.2 Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Players (2020-2025)
  • 3.2 Global Rare Gastrointestinal Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Rare Gastrointestinal Diseases Treatment, Ranking by Revenue, 2023 VS 2024 VS 2025
  • 3.4 Global Market Concentration Ratio
    • 3.4.1 Global Rare Gastrointestinal Diseases Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Rare Gastrointestinal Diseases Treatment Revenue in 2024
  • 3.5 Global Key Players of Rare Gastrointestinal Diseases Treatment Head office and Area Served
  • 3.6 Global Key Players of Rare Gastrointestinal Diseases Treatment, Product and Application
  • 3.7 Global Key Players of Rare Gastrointestinal Diseases Treatment, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

  • 4.1 Global Rare Gastrointestinal Diseases Treatment Historic Market Size by Type (2020-2025)
  • 4.2 Global Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

  • 5.1 Global Rare Gastrointestinal Diseases Treatment Historic Market Size by Application (2020-2025)
  • 5.2 Global Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Application (2026-2031)

6 North America

  • 6.1 North America Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
  • 6.2 North America Market Size by Type
    • 6.2.1 North America Rare Gastrointestinal Diseases Treatment Market Size by Type (2020-2031)
    • 6.2.2 North America Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)
  • 6.3 North America Market Size by Application
    • 6.3.1 North America Rare Gastrointestinal Diseases Treatment Market Size by Application (2020-2031)
    • 6.3.2 North America Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)
  • 6.4 North America Market Size by Country
    • 6.4.1 North America Rare Gastrointestinal Diseases Treatment Market Size by Country: 2020 VS 2024 VS 2031
    • 6.4.2 North America Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2031)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
  • 7.2 Europe Market Size by Type
    • 7.2.1 Europe Rare Gastrointestinal Diseases Treatment Market Size by Type (2020-2031)
    • 7.2.2 Europe Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)
  • 7.3 Europe Market Size by Application
    • 7.3.1 Europe Rare Gastrointestinal Diseases Treatment Market Size by Application (2020-2031)
    • 7.3.2 Europe Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)
  • 7.4 Europe Market Size by Country
    • 7.4.1 Europe Rare Gastrointestinal Diseases Treatment Market Size by Country: 2020 VS 2024 VS 2031
    • 7.4.2 Europe Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
  • 8.2 China Market Size by Type
    • 8.2.1 China Rare Gastrointestinal Diseases Treatment Market Size by Type (2020-2031)
    • 8.2.2 China Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)
  • 8.3 China Market Size by Application
    • 8.3.1 China Rare Gastrointestinal Diseases Treatment Market Size by Application (2020-2031)
    • 8.3.2 China Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)

9 Asia (excluding China)

  • 9.1 Asia Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
  • 9.2 Asia Market Size by Type
    • 9.2.1 Asia Rare Gastrointestinal Diseases Treatment Market Size by Type (2020-2031)
    • 9.2.2 Asia Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)
  • 9.3 Asia Market Size by Application
    • 9.3.1 Asia Rare Gastrointestinal Diseases Treatment Market Size by Application (2020-2031)
    • 9.3.2 Asia Rare Gastrointestinal Diseases Treatment Market Share by Application (2020-2031)
  • 9.4 Asia Market Size by Region
    • 9.4.1 Asia Rare Gastrointestinal Diseases Treatment Market Size by Region: 2020 VS 2024 VS 2031
    • 9.4.2 Asia Rare Gastrointestinal Diseases Treatment Market Size by Region (2020-2031)
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 China Taiwan
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
  • 10.2 Middle East, Africa, and Latin America Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Size by Type (2020-2031)
    • 10.2.2 Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Share by Type (2020-2031)
  • 10.3 Middle East, Africa, and Latin America Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Size by Application (2020-2031)
    • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
  • 10.4 Middle East, Africa, and Latin America Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Size by Country: 2020 VS 2024 VS 2031
    • 10.4.2 Middle East, Africa, and Latin America Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2031)
    • 10.4.3 Brazil
    • 10.4.4 Mexico
    • 10.4.5 Turkey
    • 10.4.6 Saudi Arabia
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Takeda Pharmaceutical
    • 11.1.1 Takeda Pharmaceutical Company Details
    • 11.1.2 Takeda Pharmaceutical Business Overview
    • 11.1.3 Takeda Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
    • 11.1.4 Takeda Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.1.5 Takeda Pharmaceutical Recent Development
  • 11.2 Nestle Health Science
    • 11.2.1 Nestle Health Science Company Details
    • 11.2.2 Nestle Health Science Business Overview
    • 11.2.3 Nestle Health Science Rare Gastrointestinal Diseases Treatment Introduction
    • 11.2.4 Nestle Health Science Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.2.5 Nestle Health Science Recent Development
  • 11.3 Mirum Pharmaceutical
    • 11.3.1 Mirum Pharmaceutical Company Details
    • 11.3.2 Mirum Pharmaceutical Business Overview
    • 11.3.3 Mirum Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
    • 11.3.4 Mirum Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.3.5 Mirum Pharmaceutical Recent Development
  • 11.4 Recordati Rare Diseases
    • 11.4.1 Recordati Rare Diseases Company Details
    • 11.4.2 Recordati Rare Diseases Business Overview
    • 11.4.3 Recordati Rare Diseases Rare Gastrointestinal Diseases Treatment Introduction
    • 11.4.4 Recordati Rare Diseases Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.4.5 Recordati Rare Diseases Recent Development
  • 11.5 Zealand Pharma
    • 11.5.1 Zealand Pharma Company Details
    • 11.5.2 Zealand Pharma Business Overview
    • 11.5.3 Zealand Pharma Rare Gastrointestinal Diseases Treatment Introduction
    • 11.5.4 Zealand Pharma Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.5.5 Zealand Pharma Recent Development
  • 11.6 Ironwood Pharmaceutical
    • 11.6.1 Ironwood Pharmaceutical Company Details
    • 11.6.2 Ironwood Pharmaceutical Business Overview
    • 11.6.3 Ironwood Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
    • 11.6.4 Ironwood Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.6.5 Ironwood Pharmaceutical Recent Development
  • 11.7 Ipsen
    • 11.7.1 Ipsen Company Details
    • 11.7.2 Ipsen Business Overview
    • 11.7.3 Ipsen Rare Gastrointestinal Diseases Treatment Introduction
    • 11.7.4 Ipsen Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.7.5 Ipsen Recent Development
  • 11.8 Univar Solutions
    • 11.8.1 Univar Solutions Company Details
    • 11.8.2 Univar Solutions Business Overview
    • 11.8.3 Univar Solutions Rare Gastrointestinal Diseases Treatment Introduction
    • 11.8.4 Univar Solutions Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.8.5 Univar Solutions Recent Development
  • 11.9 Tilray Brand
    • 11.9.1 Tilray Brand Company Details
    • 11.9.2 Tilray Brand Business Overview
    • 11.9.3 Tilray Brand Rare Gastrointestinal Diseases Treatment Introduction
    • 11.9.4 Tilray Brand Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.9.5 Tilray Brand Recent Development
  • 11.10 4D Molecular Therapeutics
    • 11.10.1 4D Molecular Therapeutics Company Details
    • 11.10.2 4D Molecular Therapeutics Business Overview
    • 11.10.3 4D Molecular Therapeutics Rare Gastrointestinal Diseases Treatment Introduction
    • 11.10.4 4D Molecular Therapeutics Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.10.5 4D Molecular Therapeutics Recent Development
  • 11.11 Chiasma
    • 11.11.1 Chiasma Company Details
    • 11.11.2 Chiasma Business Overview
    • 11.11.3 Chiasma Rare Gastrointestinal Diseases Treatment Introduction
    • 11.11.4 Chiasma Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.11.5 Chiasma Recent Development
  • 11.12 Orphalan
    • 11.12.1 Orphalan Company Details
    • 11.12.2 Orphalan Business Overview
    • 11.12.3 Orphalan Rare Gastrointestinal Diseases Treatment Introduction
    • 11.12.4 Orphalan Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.12.5 Orphalan Recent Development
  • 11.13 Santhera Pharmaceutical
    • 11.13.1 Santhera Pharmaceutical Company Details
    • 11.13.2 Santhera Pharmaceutical Business Overview
    • 11.13.3 Santhera Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
    • 11.13.4 Santhera Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
    • 11.13.5 Santhera Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer